title: Anti-EMMPRIN treatment of HNSCC in an ex vivo model.
authors.affiliation: Department of Surgery, Division of Otolaryngology - Head and Neck Surgery, University of Alabama at Birmingham, AL, USA.
authors.forename: Nichole
authors.initials: N
authors.lastname: Dean
authors.forename: Emily
authors.initials: E
authors.lastname: Helman
authors.forename: Joszi
authors.initials: J
authors.lastname: Aldridge
authors.forename: William
authors.initials: W
authors.lastname: Carroll
authors.forename: Scott
authors.initials: S
authors.lastname: Magnuson
authors.forename: Eben
authors.initials: E
authors.lastname: Rosenthal
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D051926:Basigin / Q000276:immunology; D015153:Blotting, Western; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D053148:Caspase 3 / Q000378:metabolism; D053181:Caspase 8 / Q000378:metabolism; D005240:Feasibility Studies; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D066298:In Vitro Techniques
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D051926:Basigin; D000255:Adenosine Triphosphate; D053148:Caspase 3; D053181:Caspase 8